Table 2. Open in new tab Patients With...

						Viral Load, IU/mL
1	48	Male	1A	F0	F, M	3 038 030	61 826
2	54	Male	3A	F0	F, A	10 969 093	14 858 439
3	41	Female	2	F2	F, C	2 942 871	8 479 148

						Viral Load, IU/mL
1	48	Male	1A	F0	F, M	3 038 030	61 826
2	54	Male	3A	F0	F, A	10 969 093	14 858 439
3	41	Female	2	F2	F, C	2 942 871	8 479 148

Table 2.

Patients With Documented Virologic Relapse

						Viral Load, IU/mL
No.	Age, y	Sex	Genotype	Fibrosis Stage	Type of Drug ^a	Baseline	Confirmation at Point of Relapse
1	48	Male	1A	F0	F, M	3 038 030	61 826
2	54	Male	3A	F0	F, A	10 969 093	14 858 439
3	41	Female	2	F2	F, C	2 942 871	8 479 148

						Viral Load, IU/mL
No.	Age, y	Sex	Genotype	Fibrosis Stage	Type of Drug ^a	Baseline	Confirmation at Point of Relapse
1	48	Male	1A	F0	F, M	3 038 030	61 826
2	54	Male	3A	F0	F, A	10 969 093	14 858 439
3	41	Female	2	F2	F, C	2 942 871	8 479 148

Baseline characteristics of patients with documented virologic relapse and their baseline and confirmation viral loads at point of relapse. All 3 patients were active drug users and had unstable housing.

^aA, amphetamines; C, cocaine; F, fentanyl; M, methadone.

This Feature Is Available To Subscribers Only